Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
Omaima Mohamed Ali,1 Hussein Ahmed El Amin,2 Yousry Lotfy Sharkawy,1 Adnan Ahmed Mohamed Ali,3 Emad Farah Mohammed Kholef,4 Wael Abd Elgwad Elsewify1 1Internal Medicine Department, Faculty of Medicine, Aswan University, Aswan, Egypt; 2Internal Medicine Department, Faculty of Medicine, Assuit Univers...
Main Authors: | Ali OM, El Amin HA, Sharkawy YL, Mohamed Ali AA, Kholef EFM, Elsewify WAE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/golgi-protein-73-versus-alpha-fetoprotein-as-a-new-biomarker-in-early--peer-reviewed-article-IJGM |
Similar Items
-
Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis
by: Xu Zhang, et al.
Published: (2023-03-01) -
Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels
by: Antonia Syriha, et al.
Published: (2024-02-01) -
A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
by: Wei-Ming Yu, et al.
Published: (2023-11-01) -
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma
by: Diamantis I. Tsilimigras, et al.
Published: (2021-02-01) -
Differences Between Alpha-Fetoprotein (AFP) and Prothrombin Induced by Vitamin K Absence or antagonist II (PIVKA-II) Values as Early Detection Method for Hepatocellular Carcinoma (HCC) and Cirrhosis
by: Bayu Eka Nugraha, et al.
Published: (2020-07-01)